Department of Otolaryngology, Hospital Universitario Central de Asturias Oviedo, Oviedo, Spain.
Eur Arch Otorhinolaryngol. 2014 Jan;271(1):23-34. doi: 10.1007/s00405-013-2384-5. Epub 2013 Feb 19.
The definitive universally accepted treatment for carotid body tumors (CBT) is surgery. The impact of surgery on cranial nerves and the carotid artery has often been underestimated. Alternatively, a few CBTs have been followed without treatment or irradiation. The goal of this study is to summarize the existing evidence concerning the efficacy and safety of surgery and external beam radiotherapy (EBRT) for CBT. Relevant articles were identified using strict criteria for systematic searches. Sixty-seven articles met the criteria which included 2,175 surgically treated patients. On the other hand, 17 articles including 127 patients treated with EBRT were found. Long-term control of the disease was obtained in 93.8% of patients who received surgical treatment and in 94.5% of the radiotherapy group. Surgery resulted in 483 (483/2,175 = 22.2%) new cranial nerve permanent deficits, whereas in the EBRT group, no new deficits were recorded (p = 0.004). The common/internal carotid artery was resected in 271 (12.5%) patients because of injury or tumor encasement, with immediate reconstruction in 212 (9.7%) patients. Three percent (60) of patients developed a permanent stroke and 1.3% (26) died due to postoperative complications. The major complications rates and the mortality after completion of the treatment also were significantly higher in surgical series compared to EBRT series. This systematic analysis highlights evidence that EBRT offers a similar chance of tumor control with lower risk of morbidity as compared to surgery in patients with CBT. This questions the traditional notion that surgery should be the mainstay of treatment.
颈动脉体瘤(CBT)的明确的普遍接受的治疗方法是手术。手术对颅神经和颈动脉的影响经常被低估。或者,一些 CBT 未经治疗或照射而被随访。本研究的目的是总结关于手术和外束放射治疗(EBRT)治疗 CBT 的疗效和安全性的现有证据。使用系统搜索的严格标准确定了相关文章。符合标准的 67 篇文章包括 2175 例手术治疗患者。另一方面,发现了 17 篇包括 127 例接受 EBRT 治疗的患者的文章。接受手术治疗的患者中有 93.8%获得了疾病的长期控制,接受放射治疗的患者中有 94.5%获得了疾病的长期控制。手术导致 483 例(483/2175=22.2%)新的颅神经永久性损伤,而 EBRT 组无新的损伤记录(p=0.004)。由于损伤或肿瘤包裹,common/internal 颈动脉在 271 例(12.5%)患者中被切除,其中 212 例(9.7%)患者立即进行了重建。3%(60)的患者发生永久性中风,1.3%(26)的患者因术后并发症死亡。与 EBRT 系列相比,手术系列中的主要并发症发生率和治疗完成后的死亡率也明显更高。这项系统分析强调了证据,即与手术相比,EBRT 为 CBT 患者提供了相似的肿瘤控制机会,且发病率较低。这对手术应该是治疗主要手段的传统观念提出了质疑。